Reply to Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)3891-3892
Number of pages2
JournalCancer
Volume125
Issue number21
DOIs
StatePublished - Nov 1 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this